Showing results (501-510 of 744) with videos related to
Sort By:
Pageof 75
The Prostate|June 8, 2020
Development and initial clinical correlation of a DNA methylation-based blood test for prostate cancerJacob J K Carson, Michael A Di Lena, David M Berman, et al.Cancer|May 13, 2006
A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican AmericansJian Gu, Xifeng Wu, Qiong Dong, et al.Urology|January 11, 2011
ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance programSumit Isharwal, Danil V Makarov, Lori J Sokoll, et al.Cancer|December 12, 2003
Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomyMasood A Khan, Patrick C Walsh, M Craig Miller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancerDanil V Makarov, Sumit Isharwal, Lori J Sokoll, et al.The Journal of Urology|December 17, 2009
Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance programJeffrey J Tosoian, Stacy Loeb, Anna Kettermann, et al.BJU International|July 2, 2016
Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary eraJeffrey J Tosoian, Meera Chappidi, Zhaoyong Feng, et al.Urology|October 18, 2002
Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 menLori J Sokoll, Leslie A Mangold, Alan W Partin, et al.BJU International|February 11, 2020
Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillanceMufaddal K Mamawala, Alexa R Meyer, Patricia K Landis, et al.Human Pathology|April 13, 2016
The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasmsGunes Guner, Justin A Bishop, Stephania M Bezerra, et al.Pageof 75